How we manage immune thrombocytopenia in the elderly-Reference-Cited by-同舟云学术

How we manage immune thrombocytopenia in the elderly

Published:2016-04-07 Issue:6 Volume:173 Page:844-856
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mahévas Matthieu¹,Michel Marc¹,Godeau Bertrand¹

Affiliation:

1. Service de Médecine Interne; Centre de référence des cytopénies auto-immunes de l'adulte; Hôpital Henri Mondor; Assistance Publique-Hôpitaux de Paris; Université Paris Est Créteil; Créteil France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14067/fullpdf

Reference95 articles.

1. Danazol therapy renders red cells resistant to osmotic lysis;Ahn;FASEB Journal,1989

2. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy;Ahsan;Journal of Nephrology,1998

3. Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol;Andres;Drugs and Aging,2003

4. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura;Arnold;Annals of Internal Medicine,2007

5. Approach to the diagnosis and management of drug-induced immune thrombocytopenia;Arnold;Transfusion Medicine Reviews,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus;Platelets;2024-05-14

2. The use of splenic embolization in immune thrombocytopenia: A systematic review and meta‐analysis;British Journal of Haematology;2024-03-28

3. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI);Journal of Clinical Medicine;2023-10-10

4. Knowledge mapping of immune thrombocytopenia: a bibliometric study;Frontiers in Immunology;2023-05-03

5. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study;Platelets;2023-01-03